Back
Chemomab Therapeutics Stock Price Chart
Stock Market Legend Shares Biggest Prediction Ever:
Click Here to See
Buy
55
CMMB
Chemomab Therapeutics
Last Price:
0.72
Seasonality Move:
-20.97%
7 Day Trial
ALL ACCESS PASS
$
7
This DeFi Coin Could 10x Soon... I Advise You Get In Now!
Discover this DeFi diamond before the next surge- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CMMB is experiencing buying pressure, which is a positive indicator for future bullish movement.
Chemomab Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.69 | Buy |
| 20-day SMA: | 0.7 | Buy |
| 50-day SMA: | 0.73 | Buy |
| 200-day SMA: | 0.78 | Sell |
| 8-day EMA: | 0.71 | Buy |
| 20-day EMA: | 0.71 | Buy |
| 50-day EMA: | 0.7 | Buy |
| 200-day EMA: | 0.92 | Sell |
Chemomab Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 54.39 | Buy |
| Chaikin Money Flow: | 13291 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.66 - 0.78) | Buy |
| Bollinger Bands (100): | (0.53 - 0.75) | Buy |
Chemomab Therapeutics Technical Analysis
| Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Chemomab Therapeutics Stock
Is Chemomab Therapeutics Stock a Buy?
- Chemomab Therapeutics share price is 0.74 while CMMB 8-day simple moving average is 0.69, which is a Buy signal.
- The stock price of CMMB is 0.74 while Chemomab Therapeutics 20-day SMA is 0.70, which makes it a Buy.
- Chemomab Therapeutics 50-day simple moving average is 0.73 while CMMB share price is 0.74, making it a Buy technically.
- CMMB stock price is 0.74 and Chemomab Therapeutics 200-day simple moving average is 0.78, creating a Sell signal.
CMMB Technical Analysis vs Fundamental Analysis
Buy
55
Chemomab Therapeutics (CMMB)
is a Buy
Is Chemomab Therapeutics a Buy or a Sell?
-
Chemomab Therapeutics stock is rated a Buy
The current Chemomab Therapeutics [CMMB] share price is $0.74. The Score for CMMB is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
Chemomab Therapeutics Stock Info
Market Cap:
10.51M
Price in USD:
0.74
Share Volume:
13.29K
Chemomab Therapeutics 52-Week Range
52-Week High:
1.89
52-Week Low:
0.42
Buy
55
Chemomab Therapeutics (CMMB)
is a Buy
Chemomab Therapeutics Share Price Forecast
-
What is the Chemomab Therapeutics stock price today?
The Chemomab Therapeutics stock price is 0.74 USD today. -
Will CMMB stock go up or go down?
Chemomab Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Chemomab Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Chemomab Therapeutics is not overvalued.
Is Chemomab Therapeutics Stock a Buy?
- Chemomab Therapeutics share price is 0.74 while CMMB 8-day exponential moving average is 0.71, which is a Buy signal.
- The stock price of CMMB is 0.74 while Chemomab Therapeutics 20-day EMA is 0.71, which makes it a Buy.
- Chemomab Therapeutics 50-day exponential moving average is 0.70 while CMMB share price is 0.74, making it a Buy technically.
- CMMB stock price is 0.74 and Chemomab Therapeutics 200-day simple moving average is 0.92, creating a Sell signal.
Fundamental Analysis of Chemomab Therapeutics
Is Chemomab Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.05 per share, and a decrease next year of $0.02 per share.
Technical Analysis of Chemomab Therapeutics
Should I short Chemomab Therapeutics stock?
- CMMB Moving Average Covergence Divergence (MACD) indicator is -0.01, suggesting Chemomab Therapeutics is a Sell
- Chemomab Therapeutics Relative Strength Index (RSI) is 54.39, which suggest Chemomab Therapeutics is overbought
- The Bollinger Bands (25) for Chemomab Therapeutics is (0.66 - 0.78), which suggest Chemomab Therapeutics is a Buy
- The Bollinger Bands (100) for Chemomab Therapeutics is (0.53 - 0.75), which suggest Chemomab Therapeutics is a Buy
* Chemomab Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.